AHA Statement on Lower Drug Costs Now Act

Tom Nickels
Executive Vice President
American Hospital Association

September 19, 2019

The American Hospital Association applauds today’s proposal that takes significant strides toward reducing out-of-control drug prices, which continue to place patients and the providers who care for them at risk. Outrageous drug prices force too many patients into rationing their drugs or leaving their prescriptions unfilled. America’s hospitals and health systems see the consequences first hand: patients coming back through our doors sicker than when they left. Not only do our patients feel it at the pharmacy counter, but the high cost of drugs threatens the ability of hospitals and health systems to acquire needed drugs for patients in their care.

We look forward to further reviewing today’s proposal and continuing to work with the Administration and the Congress to make progress on lowering drug prices.


Contact:     Colin Milligan, (202) 638-5491
                   Marie Johnson, (202) 626-2351

Related Resources

Special Bulletin
The Senate yesterday voted 51-50 to approve the Inflation Reduction Act of 2022 (H.R. 5376), a roughly $700 billion social spending package that includes…
A new AHA report highlights the significant growth in expenses across labor, drugs, and supplies, as well as the impact that rising inflation is having on…
Hospitals appreciate the support and resources that Congress have provided throughout the COVID-19 pandemic; however, additional support is needed to keep…
AHA shares proposals to lower Medicare drug prices with congress.
AHA Center for Health Innovation Market Scan
Pending federal approval, Civica Rx, the nonprofit consortium of U.S. hospitals, plans to manufacture and distribute several generic insulins, continuing its…
AHA Center for Health Innovation Market Scan
The Purchaser Business Group on Health (PBGH), a coalition of about 40 large private and public employers including Walmart, Disney, Costco and Microsoft,…